205 related articles for article (PubMed ID: 24165578)
1. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.
Liedke PE; Finkelstein DM; Szymonifka J; Barrios CH; Chavarri-Guerra Y; Bines J; Vasconcelos C; Simon SD; Goss PE
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):126-33. PubMed ID: 24165578
[TBL] [Abstract][Full Text] [Related]
2. Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage.
Martinez-Cannon BA; Zertuche-Maldonado T; de la Rosa Pacheco S; Cardona-Huerta S; Canavati-Marcos M; Gomez-Macias GS; Villarreal-Garza C
Womens Health (Lond); 2020; 16():1745506520949416. PubMed ID: 32811351
[TBL] [Abstract][Full Text] [Related]
3. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
4. The relation between health insurance coverage and clinical outcomes among women with breast cancer.
Ayanian JZ; Kohler BA; Abe T; Epstein AM
N Engl J Med; 1993 Jul; 329(5):326-31. PubMed ID: 8321261
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival.
Beinart G; Gonzalez-Angulo AM; Broglio K; Mejia J; Ruggeri A; Mininberg E; Hortobagyi GN; Valero V
Clin Breast Cancer; 2007 Dec; 7(11):867-74. PubMed ID: 18269777
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
7. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
[TBL] [Abstract][Full Text] [Related]
8. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer in octogenarian women: clinical characteristics and outcome.
Kuzan TY; Koca E; Dizdar O; Arslan C; Eren T; Yalcin S; Kucukoztas N; Aksoy S; Rahatli S; Dede DS; Altundag O; Zengin N; Ozyilkan O; Altundag K
J BUON; 2013; 18(2):328-34. PubMed ID: 23818342
[TBL] [Abstract][Full Text] [Related]
10. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
Fu AZ; Jhaveri M
J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
[TBL] [Abstract][Full Text] [Related]
11. Insurance status and the care of adult patients 19 to 64 years of age visiting the emergency department.
Mannix R; Stack AM; Chiang V
Acad Emerg Med; 2012 Jul; 19(7):808-15. PubMed ID: 22724921
[TBL] [Abstract][Full Text] [Related]
12. Medical outcomes of care for breast cancer among health maintenance organization and fee-for-service patients.
Vernon SW; Heckel V; Jackson GL
Clin Cancer Res; 1995 Feb; 1(2):179-84. PubMed ID: 9815971
[TBL] [Abstract][Full Text] [Related]
13. Disparities in survival by insurance status in patients with Hodgkin lymphoma.
Parikh RR; Grossbard ML; Green BL; Harrison LB; Yahalom J
Cancer; 2015 Oct; 121(19):3515-24. PubMed ID: 26058564
[TBL] [Abstract][Full Text] [Related]
14. Insurance status and stage of cancer at diagnosis among women with breast cancer.
Halpern MT; Bian J; Ward EM; Schrag NM; Chen AY
Cancer; 2007 Jul; 110(2):403-11. PubMed ID: 17562557
[TBL] [Abstract][Full Text] [Related]
15. Is the self-reported private health insurance status in the National Health Survey representative of private health insurance coverage in Australia?
Ranmuthugala G; Brown L; Thurecht L; Lymer S
Aust N Z J Public Health; 2010 Dec; 34(6):572-7. PubMed ID: 21134057
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
17. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
18. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
[TBL] [Abstract][Full Text] [Related]
19. The impact of public versus private insurance on trauma patients.
Jentzsch T; Neuhaus V; Seifert B; Osterhoff G; Simmen HP; Werner CM; Moos R
J Surg Res; 2016 Jan; 200(1):236-41. PubMed ID: 26248479
[TBL] [Abstract][Full Text] [Related]
20. Health characteristics associated with gaining and losing private and public health insurance: a national study.
Jerant A; Fiscella K; Franks P
Med Care; 2012 Feb; 50(2):145-51. PubMed ID: 21945971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
